Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.

Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.

Summary: Background: Allergen immunotherapy (AIT) is the only causal treatment for respiratory allergy. Long-term real-life effectiveness of AIT remains to be demonstrated beyond the evidence from randomised controlled trials (RCTs). Methods: REACT (Real world effectiveness in allergy immunotherapy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, Sarah Buchs, Julie Rask Larsen, Lisa Elliott, Mercedes Romano Rodriguez, Nick Freemantle
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Allergic rhinitis
Allergy
Allergy immunotherapy
Asthma
Effectiveness
Real-world evidence
Public aspects of medicine
RA1-1270
Acceso en línea:https://doaj.org/article/a6b5c685a2174bc59d4c97bcccb513a1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a6b5c685a2174bc59d4c97bcccb513a1

Ejemplares similares